The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. PMV Pharmaceuticals Inc shares valued at $1,520,000 were sold by ORBIMED ADVISORS LLC on Oct 23 ’25. At $1.52 per share, ORBIMED ADVISORS LLC sold 1,000,000 shares. The insider’s holdings dropped to 4,975,291 shares worth approximately $6.12 million following the completion of this transaction.
Also, OrbiMed Private Investments V, purchased 1,000,000 shares, netting a total of over 1,520,000 in proceeds.
Before that, ORBIMED ADVISORS LLC had sold 500,000 shares from its account. In a trade valued at $900,000, the 10% Owner traded PMV Pharmaceuticals Inc shares for $1.80 each. Upon closing the transaction, the insider’s holdings decreased to 500,000 shares, worth approximately $7.35 million.
As published in a research note from Oppenheimer on November 08, 2024, PMV Pharmaceuticals Inc [PMVP] has been rated up from a Perform to an Outperform and the price target has been revised to $6. Analysts at Craig Hallum started covering the stock with ‘”a Buy”‘ outlook in a report released in mid May. As of April 12, 2024, Jefferies has initiated its “Buy” rating for PMVP. Earlier on December 27, 2023, Ladenburg Thalmann initiated its rating. Their recommendation was “a Buy” for PMVP stock.
Analyzing PMVP Stock Performance
On last trading session, PMV Pharmaceuticals Inc [NASDAQ: PMVP] rose 8.85% to $1.23. The stock’s lowest price that day was $1.1102, but it reached a high of $1.2653 in the same session. During the last five days, there has been a drop of approximately -1.60%. Over the course of the year, PMV Pharmaceuticals Inc shares have dropped approximately -21.15%. Shares of the company reached a 52-week high of $1.8400 on 09/10/25 and a 52-week low of $0.8100 on 05/16/25.
Support And Resistance Levels for PMV Pharmaceuticals Inc (PMVP)
According to the 24-hour chart, there is a support level at 1.1368, which, if violated, would cause prices to drop to 1.0436. In the upper region, resistance lies at 1.2966. The next price resistance is at 1.3632. RSI (Relative Strength Index) is 45.93 on the 14-day chart, showing neutral technical sentiment.
Is PMV Pharmaceuticals Inc subject to short interest?
Stocks of PMV Pharmaceuticals Inc saw a sharp steep in short interest on 2025-11-28 dropping by -0.17 million shares to 1.35 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 1.52 million shares. A decline of -12.95% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.74 of the overall float, the days-to-cover ratio (short ratio) decline to 4.74.
Which companies own the most shares of PMV Pharmaceuticals Inc (PMVP)?
In terms of PMV Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 15.5 in the next 12 months, up nearly 1271.68% from the previous closing price of $1.13. Analysts anticipate PMV Pharmaceuticals Inc stock to reach 36 by 2025, with the lowest price target being 5. In spite of this, 4 analysts ranked PMV Pharmaceuticals Inc stock as Buy at the end of 2025. On March 02, 2022, Oppenheimer assigned a price target of “an Outperform” to the stock and upgraded coverage with a $30.
